SEC Company Response from Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704) (CLRB) — Dec 18, 2015
Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704)
Date: Dec. 18, 2015 · CIK: 0001279704 · Accession: 0001144204-15-071771
AI Filing Summary & Sentiment
Reasoning
Letter
Seaport West
155 Seaport Boulevard
Boston, MA 02210-2600
617 832 1000 main
617 832 7000 fax
December 18, 2015
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, DC 20549
Re:
Cellectar Biosciences, Inc. (CIK 0001279704)
Registration Statement on Form S-1
Ladies and Gentlemen:
This letter constitutes supplemental correspondence on behalf of Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), related to and filed together with the Company’s Registration Statement on Form S-1 (the “Registration Statement”). The Registration Statement covers the issuance and sale by the Company of shares of the Company’s common stock, $0.00001 par value per share (“Common Stock”), and warrants to purchase shares of Common Stock (the “Warrants”), together in an underwritten offering intended to raise $10,000,000.
Please direct any communications concerning the Registration Statement to the undersigned at (617) 832-1113, email—pbork@foleyhoag.com, or, in my absence, Daniel Clevenger at (617) 832-1283, email—dclevenger@foleyhoag.com. The email address of the Company’s agent for service is jcaruso@cellectar.com.
Very truly yours,
/s/
Paul Bork
Show Raw Text
CORRESP
1
filename1.htm
Seaport West
155 Seaport Boulevard
Boston, MA 02210-2600
617 832 1000 main
617 832 7000 fax
December 18, 2015
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, DC 20549
Re:
Cellectar Biosciences, Inc. (CIK 0001279704)
Registration Statement on Form S-1
Ladies and Gentlemen:
This letter constitutes supplemental
correspondence on behalf of Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), related to and filed
together with the Company’s Registration Statement on Form S-1 (the “Registration Statement”). The Registration
Statement covers the issuance and sale by the Company of shares of the Company’s common stock, $0.00001 par value per share
(“Common Stock”), and warrants to purchase shares of Common Stock (the “Warrants”), together in an underwritten
offering intended to raise $10,000,000.
Please direct any communications concerning
the Registration Statement to the undersigned at (617) 832-1113, email—pbork@foleyhoag.com, or, in my absence, Daniel
Clevenger at (617) 832-1283, email—dclevenger@foleyhoag.com. The email address of the Company’s agent for service is
jcaruso@cellectar.com.
Very truly yours,
/s/
Paul Bork
Paul Bork
cc: Daniel Clevenger, Esq.
ATTORNEYS AT LAW
BOSTON | NEW YORK | PARIS | WASHINGTON | FOLEYHOAG.COM